Patents by Inventor Colin Lindley

Colin Lindley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing modulators of p300 and/or CBP
    Patent number: 11453662
    Abstract: A process for producing a compound of the following formula (I) which process comprises: (a) treating a compound of the following formula (5) with a compound of the following formula (6) to generate an intermediate compound of the following formula (7); (b) treating a compound of formula (7) as defined above with a compound of the following formula (8); and (c) recovering a compound of formula (I) as defined above. The compound of formula (I) is a promising modulator of p300/CBP activity that has potential utility in treating cancers, including prostate cancer, haematological cancers, bladder cancer and lung cancer.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: September 27, 2022
    Assignee: CELLCENTRIC LTD
    Inventors: Paul Baguley, Donald Alan Gilbert, Gareth Harbottle, Colin Lindley, John Paul Madeley, James Vaughan Morey, David Michel Adrien Taddei, Jonathan Trevorrow, David Wood
  • MEPTAZINOL CARBAMATE PRODRUG SALTS
    Publication number: 20120165315
    Abstract: The present invention relates to salts of meptazinol carbamate prodrugs, and to their synthesis and use.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 28, 2012
    Inventors: Paul McGee, R. Melling, Jean-Luc Coudret, A. Manage, Jean-Francois Camiaux, Colin Lindley